114 related articles for article (PubMed ID: 24560204)
1. [Usefulness of urethral endoprosthesis in the management of urinary retention after brachytherapy for localized prostate cancer].
Kerkeni W; Chahwan C; Lenormand C; Dubray B; Benyoucef A; Pfister C
Prog Urol; 2014 Mar; 24(3):164-6. PubMed ID: 24560204
[TBL] [Abstract][Full Text] [Related]
2. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
3. Transurethral resection versus intermittent catheterization in patients with retention after combined brachytherapy/external beam radiotherapy for prostate cancer: intermittent catheterization.
Boone TB
J Urol; 2013 Mar; 189(3):801-2. PubMed ID: 23246852
[No Abstract] [Full Text] [Related]
4. Transurethral resection versus intermittent catheterization in patients with retention after combined brachytherapy/external beam radiotherapy for prostate cancer: transurethral resection.
Stone NN
J Urol; 2013 Mar; 189(3):800-1. PubMed ID: 23246854
[No Abstract] [Full Text] [Related]
5. [Voiding dysfunction after brachytherapy in patients with prostate cancer].
Arlandis Guzmán S; Bonillo García MA; Broseta Rico E
Arch Esp Urol; 2009 Dec; 62(10):826-7837. PubMed ID: 20065532
[TBL] [Abstract][Full Text] [Related]
6. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
[TBL] [Abstract][Full Text] [Related]
7. Two-step transurethral surgery of the prostate and permanent implant brachytherapy for patients with lower urinary tract symptoms and low- to intermediate-risk prostate cancer.
Ivanowicz AN; Wakeman CM; Hubbard RT; DeVoe WB; Haake MR; Teigland CM
Brachytherapy; 2012; 11(6):483-8. PubMed ID: 21937283
[TBL] [Abstract][Full Text] [Related]
8. Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate.
Roeloffzen EM; Monninkhof EM; Battermann JJ; van Roermund JG; Moerland MA; van Vulpen M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):76-84. PubMed ID: 20605364
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
No D; Osterberg EC; Otto B; Naftali I; Choi B
Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
[TBL] [Abstract][Full Text] [Related]
10. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
Allen ZA; Merrick GS; Butler WM; Wallner KE; Kurko B; Anderson RL; Murray BC; Galbreath RW
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):981-7. PubMed ID: 15989998
[TBL] [Abstract][Full Text] [Related]
11. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
12. Seed implant retention score predicts the risk of prolonged urinary retention after prostate brachytherapy.
Lee HK; Adams MT; Shi Q; Basillote J; Lamonica J; Miranda L; Motta J
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1445-9. PubMed ID: 19553032
[TBL] [Abstract][Full Text] [Related]
13. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW
Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T
Jpn J Clin Oncol; 2006 May; 36(5):285-9. PubMed ID: 16698803
[TBL] [Abstract][Full Text] [Related]
15. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
Sarosdy MF
Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
[TBL] [Abstract][Full Text] [Related]
16. Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy.
Landis DM; Schultz D; Cormack R; Tempany C; Beard C; Hurwitz M; O'Leary M; Albert M; Valentine K; D'Amico AV
Urology; 2005 Apr; 65(4):750-4. PubMed ID: 15833521
[TBL] [Abstract][Full Text] [Related]
17. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy.
Zhang YY; Zhang ZG; Yu YL; Chen YC; Ni KX; Wang MC; Zhao WP; Rehman F; Wan SP; Li GH
J Zhejiang Univ Sci B; 2014 Aug; 15(8):756-60. PubMed ID: 25091995
[TBL] [Abstract][Full Text] [Related]
18. The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL.
Dallas NL; Malone PR; Jones A; Doggart AJ; McConway KJ; Rogers PB
BJU Int; 2012 Aug; 110(3):383-90. PubMed ID: 22332791
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
20. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer.
Flam TA; Peyromaure M; Chauveinc L; Thiounn N; Firmin F; Cosset JM; Bernard D
J Urol; 2004 Jul; 172(1):108-11. PubMed ID: 15201748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
